Catalyst Funds Management’s Elevance Health ELV Stock Holding History

Catalyst Funds Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Buy	+6,040	New	+$2.24M	0.13%	166
2026 Q1	–	Sell	-1,880	Closed	-$659K	–	627
2025 Q4	$659K	Buy	+1,880	New	+$635K	0.15%	144
2025 Q3	–	Sell	-1,300	Closed	-$506K	–	541
2025 Q2	$506K	Buy	+1,300	New	+$523K	0.14%	198
2024 Q4	–	Sell	-400	Closed	-$208K	–	620
2024 Q3	$208K	Sell	400 -200	-33%	-$107K	0.05%	280
2024 Q2	$325K	Buy	+600	New	+$317K	0.09%	150

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Catalyst Funds Management's ELV Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Elevance Health (ELV) in Q2 2026: 6,040 shares worth $2.34M. The stake represents 0.13% of the portfolio and ranks #166 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in ELV as recently as Q4 2025.

Catalyst Funds Management first reported a position in ELV in Q2 2024 and has held it in 5 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Catalyst Funds Management held 6,040 shares of Elevance Health worth $2.34M as of Q2 2026.
Elevance Health was a new Catalyst Funds Management position in Q2 2026.
Elevance Health made up 0.13% of Catalyst Funds Management's portfolio in Q2 2026, its #166 holding.
Catalyst Funds Management first reported a position in Elevance Health in Q2 2024 and has held it in 5 quarters since.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.